Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ubiquitin-specific peptidase 5 (USP5), also known as isopeptidase T (IsoT), is a crucial deubiquitinating enzyme belonging to the ubiquitin-specific protease (USP) family. It plays a unique and essential role in maintaining cellular ubiquitin homeostasis by specifically recognizing and disassembling unanchored polyubiquitin chains into monoubiquitin. USP5 is highly implicated in various pathological conditions, particularly oncology, where its overexpression stabilizes key oncoproteins (such as SLUG, FOXM1, and beta-catenin) and promotes tumor cell proliferation, metastasis, and drug resistance. Additionally, USP5 is involved in the transmission of neuropathic and inflammatory pain signals by regulating T-type calcium channels (Cav3.2). Consequently, USP5 has emerged as an attractive therapeutic target, with several small-molecule inhibitors, such as WP1130, EOAI3402143, and vialinin A, being developed to block its catalytic activity or its zinc-finger ubiquitin-binding domain (ZnF-UBD). However, therapeutic targeting of USP5 presents challenges, as complete genetic knockout is embryonically lethal in mice, and systemic inhibition can lead to proteasome dysfunction due to the accumulation of free polyubiquitin chains.
Inhibition of deubiquitinating activity, leading to accumulation of unanchored polyubiquitin chains, proteasome inhibition, and stabilization of target proteins like p53 or degradation of oncoproteins.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ubiquitin-specific peptidase 5 (USP5).